Luis Martínez‐Martínez

19.7k total citations · 1 hit paper
330 papers, 12.0k citations indexed

About

Luis Martínez‐Martínez is a scholar working on Molecular Medicine, Epidemiology and Endocrinology. According to data from OpenAlex, Luis Martínez‐Martínez has authored 330 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 212 papers in Molecular Medicine, 105 papers in Epidemiology and 100 papers in Endocrinology. Recurrent topics in Luis Martínez‐Martínez's work include Antibiotic Resistance in Bacteria (212 papers), Antibiotics Pharmacokinetics and Efficacy (84 papers) and Bacterial Identification and Susceptibility Testing (67 papers). Luis Martínez‐Martínez is often cited by papers focused on Antibiotic Resistance in Bacteria (212 papers), Antibiotics Pharmacokinetics and Efficacy (84 papers) and Bacterial Identification and Susceptibility Testing (67 papers). Luis Martínez‐Martínez collaborates with scholars based in Spain, United States and France. Luis Martínez‐Martínez's co-authors include Álvaro Pascual, George A. Jacoby, Jesús Rodríguez‐Baño, Evelio J. Perea, Vicente J. Benedí, Sebastián Albertí, José Manuel Rodríguez-Martínez, Jorge Calvo, Antonio Doménech‐Sánchez and Jordi Vilà and has published in prestigious journals such as The Lancet, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Luis Martínez‐Martínez

324 papers receiving 11.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quinolone resistance from a transferable plasmid

1998 867 citations Luis Martínez‐Martínez, Álvaro Pascual et al. profile →

Peers

Countries citing papers authored by Luis Martínez‐Martínez

Since Specialization

Citations

This map shows the geographic impact of Luis Martínez‐Martínez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Martínez‐Martínez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Martínez‐Martínez more than expected).

Fields of papers citing papers by Luis Martínez‐Martínez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Martínez‐Martínez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Martínez‐Martínez. The network helps show where Luis Martínez‐Martínez may publish in the future.

Co-authorship network of co-authors of Luis Martínez‐Martínez

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Martínez‐Martínez. A scholar is included among the top collaborators of Luis Martínez‐Martínez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Martínez‐Martínez. Luis Martínez‐Martínez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mechanisms of resistance to ceftazidime/avibactam in mutants derived in vitro from Klebsiella pneumoniae producing OXA-48-like enzymes 2025 ·Journal of Antimicrobial Chemotherapy ·(unknown), Julia Guzmán-Puche, Marta Hernández-García, (unknown), (unknown), (unknown), Julián Torre-Cisneros, Jorge Arca-Suárez, Manuel Causse, Germán Bou, Rafael Cantón, Luis Martínez‐Martínez	0
2	A retrospective global study of the prevalence of O-serotypes of invasive Escherichia coli disease in patients admitted to tertiary care hospitals 2025 ·Epidemiology and Infection ·Jeroen Geurtsen, (unknown), Luis Martínez‐Martínez, Patricia Palacios, Jeff Powis, Matthew Sims, Peter W. M. Hermans, Olivier Barraud, Philippe Lanotte, Joshua T. Thaden, Oscar Go, Bart Spiessens, Darren Abbanat, Florian Wagenlehner, Tetsuya Matsumoto, Marc J. M. Bonten, Michal Sarnecki, Jan Poolman	0
3	Long-Term Clinical and Ecological Impact of an Antimicrobial Stewardship Program on the Incidence of Carbapenem-Resistant Klebsiella pneumoniae Infections in a High-Endemic Hospital 2024 ·Antibiotics ·(unknown), (unknown), (unknown), (unknown), Isabel Machuca, Irene Gracia-Ahufinger, Rafael Ruiz-Montero, Juan José Castón, Ángela Cano, (unknown), (unknown), Inmaculada Salcedo-Leal, Luis Martínez‐Martínez, Julián Torre‐Cisneros	1
4	The Challenge of Treating Infections Caused by Metallo‐β‐Lactamase–Producing Gram-Negative Bacteria: A Narrative Review 2024 ·Drugs ·Carmen Hidalgo‐Tenorio, Germán Bou, Antonio Oliver, (unknown), Miguel Salavert, Luis Martínez‐Martínez	8
5	Mutant prevention concentrations, in vitro resistance evolution dynamics, and mechanisms of resistance to imipenem and imipenem/relebactam in carbapenem-susceptible Klebsiella pneumoniae isolates showing ceftazidime/avibactam resistance 2024 ·Antimicrobial Agents and Chemotherapy ·(unknown), (unknown), (unknown), Salud Rodríguez-Pallares, (unknown), Eva Gato, (unknown), (unknown), (unknown), (unknown), (unknown), Juan Carlos Vázquez-Ucha, Luis Martínez‐Martínez, Jorge Arca-Suárez, Alejandro Beceiro, Germán Bou	5
6	Real-life use of cefiderocol for salvage therapy of severe infections due to carbapenem-resistant Gram-negative bacteria 2023 ·International Journal of Antimicrobial Agents ·(unknown), (unknown), N. Merino, (unknown), Isabel Machuca, (unknown), Julia Guzmán-Puche, (unknown), (unknown), (unknown), J.M. Vaquero, (unknown), Luis Martínez‐Martínez, Julián Torre‐Cisneros	9
7	Proteomic Study of the Interactions between Phages and the Bacterial Host Klebsiella pneumoniae 2023 ·Microbiology Spectrum ·Inés Bleriot, Lucía Blasco, Olga Pacios, (unknown), María López, (unknown), (unknown), Felipe Fernández-Cuenca, Álvaro Pascual, Luis Martínez‐Martínez, Jesús Oteo, María Tomás	15
8	Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports 2022 ·Enfermedades infecciosas y microbiologia clinica (English ed ) ·Nieves Larrosa, Andrés Canut-Blasco, Natividad Benito, Rafael Cantón, Emilia Cercenado, Fernando Docobo-Pérez, Javier Fernández, Jesús Guinea, (unknown), (unknown), (unknown), Ferrán Navarro, Luis Martínez‐Martínez, Antonio Oliver	1
9	Recomendaciones del Comité Español del Antibiograma (COESANT) para la realización de los Informes de Sensibilidad Antibiótica Acumulada 2022 ·Enfermedades Infecciosas y Microbiología Clínica ·Nieves Larrosa, Andrés Canut-Blasco, Natividad Benito, Rafael Cantón, Emilia Cercenado, Fernando Docobo-Pérez, Javier Fernández, Jesús Guinea, (unknown), Miguel Á. Moreno, (unknown), Ferrán Navarro, Luis Martínez‐Martínez, Antonio Oliver	3
10	Comparative study of in vitro activity of tedizolid and linezolid against Mycobacterium avium complex. 2022 ·Journal of Global Antimicrobial Resistance ·(unknown), Pilar Ruiz, Luis Martínez‐Martínez, Manuel Causse	3
11	Phenotypic and Genomic Comparison of Klebsiella pneumoniae Lytic Phages: vB_KpnM-VAC66 and vB_KpnM-VAC13 2021 ·Viruses ·Olga Pacios, Laura Fernández-García, Inés Bleriot, Lucía Blasco, Antón Ambroa, María López, (unknown), Felipe Fernández-Cuenca, Jesús Oteo, Álvaro Pascual, Luis Martínez‐Martínez, Pilar Domingo‐Calap, María Tomás	14
12	Genomic analysis of 40 prophages located in the genomes of 16 carbapenemase-producing clinical strains of Klebsiella pneumoniae 2020 ·Microbial Genomics ·Inés Bleriot, Rocío Trastoy, Lucía Blasco, Felipe Fernández-Cuenca, Antón Ambroa, Laura Fernández-García, Olga Pacios, Elena Pérez‐Nadales, Julián Torre‐Cisneros, Jesús Oteo, Ferrán Navarro, Elisenda Miró, Álvaro Pascual, Germán Bou, Luis Martínez‐Martínez, María Tomás	26
13	High-risk clones and novel sequence type ST4497 of Klebsiella pneumoniae clinical isolates producing different alleles of NDM-type and other carbapenemases from a single tertiary-care centre in Egypt 2020 ·International Journal of Antimicrobial Agents ·(unknown), Pilar Egea, (unknown), Marta Fernández-Martínez, Manuel Causse, Elena Pérez‐Nadales, (unknown), (unknown), (unknown), (unknown), (unknown), Luis Martínez‐Martínez	10
14	Combined Use of the Ab105-2φΔCI Lytic Mutant Phage and Different Antibiotics in Clinical Isolates of Multi-Resistant Acinetobacter baumannii 2019 ·Microorganisms ·Lucía Blasco, Antón Ambroa, María López, Laura Fernández-García, Inés Bleriot, Rocío Trastoy, José Ramos-Vivas, Tom Coenye, Felipe Fernández-Cuenca, Jordi Vilà, Luis Martínez‐Martínez, Jesús Rodríguez‐Baño, Álvaro Pascual, José Miguel Cisneros, Jerónimo Pachón, Germán Bou, María Tomás	41
15	Pneumococcal meningitis in Cantabria (Spain) in the pneumococcal conjugate vaccine era (2001-2015) 2017 ·Archivos Argentinos de Pediatria ·(unknown), (unknown), (unknown), Luis Martínez‐Martínez, (unknown)	2
16	Correlación entre el sistema de MALDI-TOF Vitek-MSTM y los métodos convencionales de identificación de bacterias causantes de infección gastrointestinal 2016 ·Revista española de quimioterapia. Suplemento ·Carlos Ruiz de Alegría Puig, Amaia Aguirre-Quiñonero, (unknown), (unknown), Luis Martínez‐Martínez	1
17	Epidemiologic and Clinical Impact of Acinetobacter baumannii Colonization and Infection 2014 ·Medicine ·(unknown), M.E. Cano, Eva Gato, José Garnacho‐Montero, José Miguel Cisneros, (unknown), Felipe Fernández-Cuenca, Luis Martínez‐Martínez, Jordi Vilà, Álvaro Pascual, María Tomás, Germán Bou, Jesús Rodríguez‐Baño	46
18	Klebsiella pneumoniae AcrAB Efflux Pump Contributes to Antimicrobial Resistance and Virulence 2009 ·Antimicrobial Agents and Chemotherapy ·Emma Padilla, Enrique Llobet, Antonio Doménech‐Sánchez, Luis Martínez‐Martínez, José A. Bengoechea, Sebastián Albertí	325
19	Recomendaciones para la selección de antimicrobianos en el estudio de la sensibilidad in vitro con sistemas automáticos y semiautomáticos 2007 ·Enfermedades Infecciosas y Microbiología Clínica ·Rafael Cantón, Juan-Ignacio Alós, Fernando Baquero, Jorge Calvo, José Campos, Francisco Javier Castillo, Emilia Cercenado, M.Á. Domínguez, Josefina Liñares, Lorena López‐Cerero, Francesc Marco, Beatriz Mirelis, María‐Isabel Morosini, Ferrán Navarro, Antonio Oliver, Emilio Pérez‐Trallero, Cármen Torres, Luis Martínez‐Martínez	13
20	Actividad in vitro de azitromicina frente a aislamientos clínicos de Acinetobacter baumannii 2003 ·Revista española de quimioterapia. Suplemento ·Felipe Fernández-Cuenca, Álvaro Pascual, Luis Martínez‐Martínez, Evelio J. Perea	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact